Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPOAFNCStrial: L-carnitine for prevention of postoperative atrial fibrillation after non-cardiac thoracic surgery
jRCTs011200020Completed
- Sponsor
- Japanese Association for Thoracic Surgery
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of levocarnitine in bronchial carcinoma, esophageal cancer and Atrial fibrillation (AFib), sponsored by Japanese Association for Thoracic Surgery. Primary endpoint: Postoperative atrial fibrillation incidence. Started Mar 2021; status: completed.
02
Drugs
levocarnitine
03
Conditions
bronchial carcinomaesophageal cancerAtrial fibrillation (AFib)
Beyond the preview
Go deeper on jRCTs011200020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011200020.